Patents Assigned to HITACHI CHEMICAL COMPANY AMERICA, LTD
  • Patent number: 10542745
    Abstract: Disclosed are methods, device kits, and systems for improved quantification of mRNA from whole blood. More particularly, the devices and kites related thereto are useful for the controlled and repeatable ex vivo stimulation of whole blood.
    Type: Grant
    Filed: October 31, 2011
    Date of Patent: January 28, 2020
    Assignees: Hitachi Chemical Co., Ltd., Hitachi Chemical Company America, Ltd.
    Inventors: Masato Mitsuhashi, Taku Murakami
  • Patent number: 9790542
    Abstract: Some embodiments provide for a device that collects vesicles and vesicle-like materials from biological fluids. Such devices include at least one sample loading region; at least one corresponding vesicle-capture material, wherein said vesicle-capture material includes glass-like materials; and at least one corresponding sample receiving region, wherein passage of the biological fluid from the sample loading region through the vesicle-capture material and into the sample receiving region results in the capture of vesicles. Additional embodiments provide for a method of isolating vesicles and vesicle-like materials from biological fluids.
    Type: Grant
    Filed: January 7, 2015
    Date of Patent: October 17, 2017
    Assignees: HITACHI CHEMICAL CO., LTD., HITACHI CHEMICAL COMPANY AMERICA, LTD.
    Inventor: Masato Mitsuhashi
  • Patent number: 9719129
    Abstract: Provided is a device that collects vesicles and vesicle-like materials from biological fluids. Such devices comprise at least one sample loading region; at least one corresponding vesicle-capture material, wherein said vesicle-capture material comprises glass-like materials; and at least one corresponding sample receiving region, wherein passage of the biological fluid from the sample loading region through the vesicle capture material and into the sample receiving region results in the capture of vesicles. Additional methods provide for a method of isolating vesicles and vesicle-like materials from biological fluids are also provided.
    Type: Grant
    Filed: June 10, 2011
    Date of Patent: August 1, 2017
    Assignees: HITACHI CHEMICAL CO., LTD., HITACHI CHEMICAL COMPANY AMERICA, LTD.
    Inventor: Masato Mitsuhashi
  • Patent number: 9662649
    Abstract: Provided herein are devices and methods for the capture or isolation of a biomarker from a biological sample. In several embodiments, the device comprises a loading region, a filter material, and a receiving region. In particular, in several embodiments, biological fluid is passed from the loading region through the filter material and into the receiving region, thereby resulting in capture or isolation of a biomarker.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: May 30, 2017
    Assignees: HITACHI CHEMICAL COMPANY AMERICA, LTD., HITACHI CHEMICAL COMPANY LTD.
    Inventors: Masato Mitsuhashi, Mieko Ogura
  • Patent number: 9597682
    Abstract: Provided herein are devices and methods for the capture or isolation of a biomarker from a biological sample. In several embodiments, the device comprises a loading region, a filter material, and a receiving region. In particular, in several embodiments, biological fluid is passed from the loading region through the filter material and into the receiving region, thereby resulting in capture or isolation of a biomarker.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: March 21, 2017
    Assignees: HITACHI CHEMICAL COMPANY AMERICA, LTD., HITACHI CHEMICAL COMPANY LTD.
    Inventors: Masato Mitsuhashi, Mieko Ogura
  • Patent number: 9150920
    Abstract: Embodiments of the invention relate generally to ex vivo methods of quantifying expression of interferon responsive genes and characterizing an individual's potential responsiveness to interferon administration. Certain embodiments relate to methods to monitor the efficacy of ongoing interferon therapy by evaluating expression of interferon responsive genes before and after interferon administration.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: October 6, 2015
    Assignees: HITACHI CHEMICAL CO., LTD., HITACHI CHEMICAL COMPANY AMERICA, LTD, THE CLEVELAND CLINIC FOUNDATION
    Inventors: Masato Mitsuhashi, Ernest C. Borden